Starling Oncology Q2 EPS USD -0.08
STLN•Q2 results
Aug. 6 (Reuters) - Starling Oncology Q2 net income USD -9.8 million.
- Q2 gross profit USD 27.2 million
Related News
OneMain EVP & COO Micah R. Conrad disposes of 5,000 common shares worth $327,005
OMF•
Kingstone Q2 FY26 net income climbs 37.5% to $15.47 million; net premiums earned rise 30.8% to $60.47 million
KINS•
Reliance Global sells 251,666 shares to White Lion Capital for about $716,000
RELI•
Liberty Live Q2 FY26 net loss widens to USD 268.66 million; revenue rises to USD 147.06 million
LLYVA•
I3 Verticals Q3 Revenue USD 53.067 Million Vs. IBES Estimate USD 55 Million
IIIV•